Dow Down 0.09% Nasdaq Down 0.45%

Geron Corporation (GERN)

-NasdaqGS
2.19 Down 0.06(2.67%) 10:13AM EDT - Nasdaq Real Time Price
Prev Close:2.25
Open:2.22
Bid:2.19 x 14100
Ask:2.20 x 11800
1y Target Est:4.13
Beta:2.66
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.17 - 2.23
52wk Range:1.31 - 7.36
Volume:351,446
Avg Vol (3m):2,848,430
Market Cap:343.57M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 2.67%343.57M
BMYUp 0.49%85.81B
GSKUp 0.47%114.35B
NVSUp 0.49%228.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):289.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-2.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback